Health as an Economic Engine

The 2025 TransVision Conference in Madrid made one message clear: longevity is no longer
just a biomedical pursuit, it is an economic imperative.
As Lars Hartenstein, Director of the McKinsey Health Institute, emphasized, “If we extend not
only life expectancy but healthy life expectancy, Spain could see up to a 12% increase in GDP
by 2040.” Madrid, currently the European city with the highest healthy life expectancy, may
become a benchmark for urban longevity.

This vision echoes the emerging concept of the Longevity Dividend, first articulated in
geroscience and now embraced by economists: the gains from healthier aging are lower
healthcare costs, higher labor participation, and new market sectors that can transform national
economies

Why Longevity Matters for Growth

Potential Benefits:

● Economic Productivity: As Woods argued, “Healthy populations age into assets, not
liabilities.”
● Innovation: Expanding markets in biotech, digital health, housing, and nutrition are
generating new ecosystems around healthy longevity.
● Public Savings: Reduced chronic disease burden alleviates pressure on healthcare and
social security systems.

Strategic Challenges:

● Access and Equity: As Hartenstein warned, longevity technologies must not deepen
health inequality.
● Labor Market Adaptation: Societies must integrate senior professionals and redesign
lifelong learning pathways.
● Sustainability and Inclusion: The economic model must ensure that gains in longevity
are environmentally and socially sustainable.

Evidence from Research

TransVision featured pioneering work from across biomedicine and economics.

● Dr. Eduardo Díaz Rubio, President of Spain’s Royal National Academy of Medicine,
presented the Geroscience National Strategy (2026–2030), which positions aging
biology as a foundation for public health and economic policy.
● José Crespo Barrios (Regeneratics) highlighted vascular aging as one of the most costly
and preventable sources of morbidity, suggesting that “targeting inflammation could
have GDP scale effects by reducing healthcare expenditure.”
● Case studies such as María Branyas Morera, the 117 year old studied by the Josep
Carreras Institute, illustrated the power of lifestyle, microbiome, and genetics to extend
functional life by 10–15 biological years.

Opportunities and Risks

Opportunities:

● Growth in biotech, preventive medicine, and regenerative therapies.
● New industries in longevity housing, silver tourism, and wellness tech.
● Cities like Madrid and Barcelona positioning as European longevity hubs.

Risks:

● Unequal access to interventions may widen economic disparities.
● Overreliance on technological fixes may neglect social determinants of health.
● Without clear regulation, investment could outpace scientific validation.

How to Approach Responsibly

Experts at TransVision agreed that longevity must be pursued with both scientific and policy
discipline. Dr. Andrea Maier stressed that “personalized gerodiagnostics and tailored
interventions should become the backbone of public health.”

For policymakers and investors, this means aligning incentives across healthcare, labor, and
innovation systems.

How TAMVER CONSULTING Supports Clients

At TAMVER CONSULTING, we assist governments, investors, and organizations in harnessing
the Longevity Economy responsibly.

Our services include:
● Policy Modeling: Estimating macroeconomic returns from investments in healthspan.
● Fiscal Impact Analysis: Quantifying savings from reduced chronic disease burden.
● Strategic Foresight: Designing longevity ready workforce and innovation ecosystems.

We help clients turn the promise of longevity into sustainable, measurable growth, linking
science, policy, and economics in one coherent strategy.

Conclusion

The evidence from TransVision 2025 suggests a turning point: longevity has moved from the
laboratory to the balance sheet.
The future economy will not be defined merely by years lived, but by years lived in health and
productivity.
As the field matures, those who integrate longevity into national and corporate strategy today
will lead the next era of resilient, human centered growth.